Antipeptide antisera define neutralizing epitopes on the adenovirus hexon

Area of Science:

• Virology
• Immunology
• Structural Biology

Background:

• The adenovirus (Ad) hexon protein is a major component of the viral capsid.
• Hexon contains antigenic determinants responsible for both group-specific and type-specific immune responses.
• Identifying type-specific determinants is crucial for understanding Ad immunity and developing targeted interventions.

Purpose of the Study:

• To identify type-specific antigenic determinants on the Ad2 hexon protein.
• To investigate the role of these determinants in viral neutralization and host immune responses.

Main Methods:

• Synthesis of peptides corresponding to surface-exposed loops (L1 and L2) of the Ad2 hexon.
• Generation of antisera against synthesized peptides.
• Enzyme-Linked Immunosorbent Assay (ELISA) to assess antibody binding.
• Immunofluorescence and neutralization assays to evaluate effects on virus infectivity.
• Examination of human serum for antibodies against identified epitopes.

Main Results:

• Antisera against loop 1 (L1) and loop 2 (L2) peptides bound to native hexon and blocked viral infectivity.
• The L1 peptide inhibited antiserum binding to native hexon and abolished its neutralizing activity.
• Neither L1- nor L2-specific antisera neutralized Ad4 or Ad40, indicating type specificity.
• Neutralization was not due to inhibited viral attachment, as virions were internalized similarly.
• Antibodies against L1 and L2 epitopes were detected in human serum post-Ad2 infection.

Conclusions:

• Variable regions on the Ad2 hexon surface, specifically L1 and L2, represent type-specific neutralizing antigenic determinants.
• These findings highlight the role of surface-exposed epitopes in adenovirus neutralization and host immunity.
• The identified epitopes could be targets for future antiviral strategies or diagnostic tools.